Type-1 cannabinoid receptor signaling in neuronal development

Pharmacology

Volumn 90, Issue 1-2, 2012, Pages 19-39

  Gaffuri, Anne Lise ^a   Ladarre, Delphine ^a   Lenkei, Zsolt ^a  

^a Brain Plasticity Unit   (France)

Author keywords

Axonal tracts; Brain development; GPCR; Neuritogenesis

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABIS; DRONABINOL; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR;

BRAIN DEVELOPMENT; EMBRYO DEVELOPMENT; HUMAN; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROTRANSMISSION; NONHUMAN; PARACRINE SIGNALING; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTOGENESIS;

ANIMALS; BRAIN; ENDOCANNABINOIDS; HUMANS; NEURONS; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84863511021     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000339075     Document Type: Review

References (112)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned CDNA. Nature 1990; 346: 561-564.
2. Freund TF, Hajos N: Excitement reduces inhibition via endocannabinoids. Neuron 2003; 38: 362-365.
3. Bacci A, Huguenard JR, Prince DA: Long-lasting self-inhibition of neocortical inter-neurons mediated by endocannabinoids. Nature 2004; 431:312-316.
4. Heifets BD, Castillo PE: Endocannabinoid signaling and long-term synaptic plasticity. Ann Rev Physiol 2009; 71: 283-306.
5. Begbie J, Doherty P, Graham A: Cannabi-noid receptor, CB1, expression follows neu-ronal differentiation in the early chick embryo. J Anat 2004; 205:213-218.
6. Watson S, Chambers D, Hobbs C, Doherty P, Graham A: The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation. Mol Cell Neurosci 2008; 38:89-97.
7. Mulder J, Aguado T, Keimpema E, Barabas K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzman M, Lu HC, Galve-Roperh I, Harkany T: Endocan-nabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci USA 2008; 105:8760-8765.
8. Vitalis T, Laine J, Simon A, Roland A, Leter-rier C, Lenkei Z: The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro. Eur J Neurosci 2008; 28:1705-1718.
9. Gomez M, Hernandez ML, Pazos MR, Tolon RM, Romero J, Fernandez-Ruiz J: Colocal-ization of CB1 receptors with L1 and Gap-43 in forebrain white matter regions during fetal rat brain development. Evidence for a role of these receptors in axonal growth and guidance. Neuroscience 2008; 153: 687-699.
10. Wu CS, Zhu J, Wager-Miller J, Wang S, O'Leary D, Monory K, Lutz B, Mackie K, Lu HC: Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur J Neu-rosci 2010; 32: 693-706.
11. Argaw A, Duff G, Zabouri N, Cecyre B, Chaine N, Cherif H, Tea N, Lutz B, Ptito M, Bouchard JF: Concerted action of CB1 can-nabinoid receptor and deleted in colorectal cancer in axon guidance. J Neurosci 2011; 31: 1489-1499.
12. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T: Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 2007; 316: 1212-1216.
13. Kim D, Thayer SA: Cannabinoids inhibit the formation of new synapses between hippo-campal neurons in culture. J Neurosci 2001; 21:RC146.
14. Bernard C, Milh M, Morozov YM, Ben-Ari Y, Freund TF, Gozlan H: Altering cannabi-noid signaling during development disrupts neuronal activity. Proc Natl Acad Sci USA 2005; 102: 9388-9393.
15. Keimpema E, Barabas K, Morozov YM, Tortoriello G, Torii M, Ca meron G, Yanagawa Y, Watanabe M, Mackie K, Harkany T: Differential subcellular recruitment of monoacyl-glycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J Neurosci 2010; 30: 13992-14007.
16. Williams EJ, Walsh FS, Doherty P: The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J Cell Biol 2003; 160:481-486.
17. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Ganga-dharan U, Hobbs C, Di Marzo V, Doherty P: Cloning of the first Sn1-Dag lipases points to the spatial and temporal regulation of endo-cannabinoid signaling in the brain. J Cell Biol 2003; 163: 463-468.
18. Berghuis P, Dobszay MB, Wang X, Spano S, Ledda F, Sousa KM, Schulte G, Ernfors P, Mackie K, Paratcha G, Hurd YL, Harkany T: Endocannabinoids regulate interneuron migration and morphogenesis by transactivat-ing the TrkB receptor. Proc Natl Acad Sci USA 2005; 102: 19115-19120.
19. Zorina Y, Iyengar R, Bromberg KD: Canna-binoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth. J Biol Chem 2010; 285: 1358-1370.
20. Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernandez-Ruiz JJ: Analysis of cannabi-noid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999; 33:181-191.
21. Turu G, Hunyady L: Signal transduction of the CB1 cannabinoid receptor. J Mol Endo-crinol 2010; 44: 75-85.
22. Glass M, Felder CC: Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in stria-tal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 1997; 17:5327-5333.
23. Childers SR, Deadwyler SA: Role of cyclic AMP in the actions of cannabinoid receptors. Biochem Pha rmacol 1996; 52: 819-827.
24. 2+ channels in a neuronal expression system. Mol Pharmacol 1996; 49:707-714.
25. Kobilka BK, Deupi X: Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 2007; 28: 397-406.
26. Rosenbaum DM, Rasmussen SGF, Kobilka BK: The structure and function of G-pro-tein-coupled receptors. Nature 2009; 459: 356-363.
27. Ballesteros J, Palczewski K: G protein-coupled receptor drug discovery. Implications from the crystal structure of rhodopsin. Curr Opin Drug Discov Devel 2001; 4: 561-574.
28. Shapiro DA, Kristiansen K, Weiner DM, Kroeze WK, Roth BL: Evidence for a model of agonist-induced activation of 5-hydroxy-tryptamine 2a serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem 2002; 277: 18244-18244.
29. Seifert R, Wenzel-Seifert K: Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002; 366:381-416.
30. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maf-frand JP, Le Fur G, Casellas P: A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein ki-nase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 1997; 272:22330-22339.
31. 2+ currents by reversal of tonic cb1 cannabinoid receptor activity. Mol Pharmacol 1998; 54:1064-1072.
32. Hillard CJ, Muthian S, Kearn CS: Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. FEBS Lett 1999; 459:277-281.
33. Ballesteros J, Kitanovic S, Guarnieri F, Davies P, Fromme BJ, Konvicka K, Chi L, Millar R P, Davidson JS, Weinstein H, Sealfon SC: Functional microdomains in G-protein-coupled receptors-the conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J Biol Chem 1998; 273: 10445-10453.
34. D'antona AM, Ahn KH, Kendall DA: Mutations of CB1 t210 produce active and inactive receptor forms. Correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry 2006; 45: 5606-5617.
35. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF: Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAer-gic t ransmission. J Neurosci 2001; 21: 9506-9518.
36. Bodor AL, Katona I, Nyiri G, Mackie K, Le-dent C, Hajos N, Freund TF: Endocannabi-noid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 2005; 25: 6845-6856.
37. Coutts AA, Anavi-Goffer S, Ross RA, Mac-Ewan DJ, Mackie K, Pertwee RG, Irving AJ: Agonist-induced internalization and trafficking of cannabinoid CB(1) receptors in hippocampal neurons. J Neurosci 2001; 21: 2425-2433.
38. Leterrier C, Laine J, Darmon M, Boudin H, Rossier J, Lenkei Z: Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J Neurosci 2006; 26: 3141-3153.
39. Leterrier C, Bonnard D, Carrel D, Rossier J, Lenkei Z: Constitutive endocytic cycle of the CB1 cannabinoid receptor. J Biol Chem 2004; 279: 36013-36021.
40. Ellis J, Pediani JD, Canals M, Milasta S, Mil-ligan G: Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and-independent coordinated alterations of receptor localization and function. J Biol Chem 2006; 281: 38812-38824.
41. Tappe-Theodor A, Agarwal N, Katona I, Rubino T, Martini L, Swiercz J, Mackie K, Monyer H, Parolaro D, Whistler J, Kuner T, Kuner R: A molecular basis of analgesic tolerance to cannabinoids. J Neurosci 2007; 27: 4165-4177.
42. Wu DF, Yang LQ, Goschke A, Stumm R, Brandenburg LO, Liang YJ, Hollt V, Koch T: Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J Neurochem 2008; 104: 1132-1143.
43. Rozenfeld R, Devi LA: Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J 2008; 22: 2311-2322.
44. Grimsey NL, Graham ES, Dragunow M, Glass M: Cannabinoid receptor 1 trafficking and the role of the intracellular pool: implications for therapeutics. Biochem Pharmacol 2010; 80:1050-1062.
45. McDonald NA, Henstridge CM, Connolly CN, Irving AJ: An essential role for constitutive endocytosis, but not activity, in the axo-nal targeting of the CB1 cannabinoid receptor. Mol Pha rmacol 2007; 71: 976-984.
46. Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E, Matias I, Delamarre A, Metna-Laurent M, Cannich A, Hebert-Chatelain E, Mulle C, Ortega-Gutierrez S, Martin-Fontecha M, Klugmann M, Guggenhuber S, Lutz B, Gertsch J, Chaouloff F, Lopez-Rodriguez ML, Grandes P, Rossignol R, Marsicano G: Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci 2012; 15:558-564.
47. Carrel D, Simon A, Emerit MB, Rivals I, Le-terrier C, Biard M, Hamon M, Darmon M, Lenkei Z: Axonal targeting of the 5-HT1b serotonin receptor relies on structure-specific constitutive activation. Traffic 2011; 12: 1501-1520.
48. Turu G, Simon A, Gyombolai P, Szidonya L, Bagdy G, Lenkei Z, Hunyady L: The role of diacylglycerol lipase in constitutive and an-giotensin AT1 receptor-stimulated cannabi-noid CB1 receptor activity. J Biol Chem 2007; 282:7753-7757.
49. Mohammad S, Baldini G, Granell S, Narducci P, Martelli AM: Constitutive traffic of mel-anocortin-4 receptor in neuro2a cells and immortalized hypothalamic neurons. J Biol Chem 2007; 282: 4963-4974.
50. Marion S, Weiner DM, Caron MG: RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2C receptor isoforms. J Biol Chem 2004; 279: 2945-2954.
51. Chanrion B, Mannoury la Cour C, Gavarini S, Seimandi M, Vincent L, Pujol JF, Bockaert J, Marin P, Millan MJ: Inverse agonist and neutral antagonist actions of antidepres-sants at recombinant and native 5-hydroxy-tryptamine2C receptors. Differential modulation of cell surface expression and signal transduction. Mol Pharmacol 2008; 73: 748-757.
52. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, Murray SR, Von Zas-trow M: Modulation of postendocytic sorting of g protein-coupled receptors. Science 2002; 297:615-620.
53. Morris DP, Price RR, Smith MP, Lei B, Schwinn DA: Cellular trafficking of human alpha1a-adrenergic receptors is continuous and primarily agonist-independent. Mol Pharmacol 2004; 66:843-854.
54. Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM: High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 2000; 408:860-864.
55. Holliday ND, Holst B, Rodionova EA, Schwartz TW, Cox HM: Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol Endocrinol 2007; 21:3100-3112.
56. Jacquier V, Prummer M, Segura JM, Pick H, Vogel H: Visualizing odorant receptor trafficking in living cells down to the single-molecule level. Proc Natl Acad Sci USA 2006; 103:14325-14330.
57. Howlett AC, Reggio PH, Childers SR, Hamp-son RE, Ulloa NM, Deutsch DG: Endocan-nabinoid tone versus constitutive activity of cannabinoid receptors. Br J Pharmacol 2011; 163: 1329-1343.
58. Pertwee RG, Howlett AC, Abood ME, Alexander SPH, Di Marzo V, Elphick MR, Greas-ley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA: International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol Rev 2010; 62: 588-631.
59. Alger BE, Kim J: Supply and demand for en-docannabinoids. Trends Neurosci 2011; 34: 304-315.
60. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandel-baum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-1949.
61. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K: 2-Arachidonoylgylcerol-a possible endogenous cannabinoid receptor-ligand in brain. Biochem Biophys Res Commun 1995; 215: 89-97.
62. Bisogno T, Ligresti A, Di Marzo V: The en-docannabinoid signalling system. Biochemical aspects. Pharmacol Biochem Behav 2005; 81: 224-238.
63. D'antona AM, Ahn KH, Wang L, Mierke DF, Lucas-Lenard J, Kendall DA: A cannabinoid receptor 1 mutation proximal to the dry motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation. Brain Res 2006; 1108:1-11.
64. Pertwee RG: Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 2005; 76: 1307-1324.
65. Oates J, Watts A: Uncovering the intimate relationship between lipids, cholesterol and GPCR activation. Curr Opin Struct Biol 2011; 21:802-807.
66. Phillips R, Ursell T, Wiggins P, Sens P: Emerging roles for lipids in shaping membrane-protein function. Nature 2009; 459: 379-385.
67. Mátyás F, Yanovsky Y, Mackie K, Kelsch W, Misgeld U, Freund TF: Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 2006;137(1): 337-361.
68. Starke K: Presynaptic receptors. Annu Rev Pharmacol Toxicol 1981; 21:7-30.
69. Herkenham M, Lynn AB, Johnson MR, Mel-vin LS, de Costa BR, Rice KC: Characterization and localization of cannabinoid receptors in rat brain. A quantitative in vitro au-toradiographic study. J Neurosci 1991; 11: 563-583.
70. Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, Fernandez-Ruiz JJ: Atypical location of can-nabinoid receptors in white matter areas during rat brain development. Synapse 1997; 26: 317-323.
71. Berrendero F, Garcia-Gil L, Hernandez ML, Romero J, Cebeira M, de Miguel R, Ramos JA, Fernandez-Ruiz JJ: Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 1998; 125:3179-3188.
72. Wang X, Dow-Edwards D, Keller E, Hurd YL: Preferential limbic expression of the cannabinoid receptor mrna in the human fetal brain. Neuroscience 2003; 118: 681-694.
73. Morozov YM, Freund TF: Post-natal development of type 1 cannabinoid receptor im-munoreactivity in the rat hippocampus. Eur J Neurosci 2003; 18: 1213-1222.
74. Marin O, Rubenstein JLR: Cell migration in the forebrain. Ann Rev Neurosci 2003; 26: 441-483.
75. Rueda D, Navarro B, Martinez-Serrano A, Guzman M, Galve-Roperh I: The endocan-nabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J Biol Chem 2002; 277: 46645-46650.
76. Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzman M, Galve-Roperh I: The endocan-nabinoid system drives neural progenitor proliferation. FASEB J 2005; 19: 1704-1706.
77. Jin K, Xie L, Kim SH, Parmentier-Batteur S, Sun Y, Mao XO, Childs J, Greenberg DA: Defective adult neurogenesis in CB1 cannabi-noid receptor knockout mice. Mol Pharmacol 2004; 66:204-208.
78. Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, Zhang X: Cannabinoids promote embryonic and adult hippocampus neuro-genesis and produce anxiolytic-and antide-pressant-like effects. J Clin Invest 2005; 115: 3104-3116.
79. Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzman M, Galve-Roperh I: The endocan-nabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 2006; 26: 1551-1561.
80. Molina-Holgado E, Vela JM, Arevalo-Mar-tin A, Almazan G, Molina-Holgado F, Borrell J, Guaza C: Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci 2002; 22:9742-9753.
81. Wolf SA, Bick-Sander A, Fabel K, Leal-Gali-cia P, Tauber S, Ramirez-Rodriguez G, Mul ler A, Melnik A, Waltinger TP, Ullrich O, Kem-permann G: Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neuro-genesis. Cell Commun Signal 2010; 8: 12.
82. Soltys J, Yushak M, Mao-Draayer Y: Regulation of neural progenitor cell fate by anan-damide. Biochem Biophys Res Commun 2010; 400:21-26.
83. Sideris A, Bekker T, Chan WS, Montoya-Gacharna JV, Blanck TJ, Recio-Pinto E: A role for the cannabinoid 1 receptor in neuro-nal differentiation of adult spinal cord progenitors in vitro is revealed through pharmacological inhibition and genetic deletion. Front Neurosci 2012; 6:4.
84. Oudin MJ, Gajendra S, Williams G, Hobbs C, Lalli G, Doherty P: Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain. J Neurosci 2011; 31:4000-4011.
85. Kriegstein A, Alvarez-Buylla A: The glial nature of embryonic and adult neural stem cells. Ann Rev Neurosci 2009; 32:149-184.
86. Banker G, Goslin K: Culturing Nerve Cells. Cambridge, MIT Press, 1991.
87. Cabral GA, Mcnerney PJ, Mishkin EM: Interaction of delta-9- tetrahydrocannabinol with rat B103 neuroblastoma-cells. Arch Toxicol 1987; 60:438-449.
88. Ishii I, Chun J: Anandamide-induced neuro-blastoma cell rounding via the CB1 cannabi-noid receptors. Neuroreport 2002; 13: 593-596.
89. Zhou D, Song ZH: CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1e-115 cells. J Neurosci Res 2001; 65: 346-353.
90. Chemin J, Nargeot J, Lory P: Neuronal T-type alpha 1H calcium channels induce neu-ritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. Journal of Neuroscience 2002; 22: 6856-6862.
91. Jung KM, Astarita G, Thongkham D, Pio-melli D: Diacylglycerol lipase-alpha and-beta control neurite outgrowth in neuro-2a cells through distinct molecular mechanisms. Mol Pharmacol 2011; 80:60-67.
92. He JC, Gomes I, Nguyen T, Jayaram G, Ram PT, Devi LA, Iyengar R: The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3. J Biol Chem 2005; 280: 33426-33434.
93. Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Bivona TG, Philips MR, Devi LA, Iyengar R: Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-trig-gered proteasomal degradation of Rap1Ga-pII. J Biol Chem 2005; 280:11413-11421.
94. Kavalali ET, Klingauf J, Tsien RW: Activity-dependent regulation of synaptic clustering in a hippocampal culture system. Proc Natl Acad Sci USA 1999; 96:12893-12900.
95. Ma L, Zablow L, Kandel ER, Siegelbaum SA: Cyclic AMP induces functional presynaptic boutons in hippocampal CA3-CA1 neuronal cultures. Nat Neurosci 1999; 2: 24-30.
96. Arimura N, Kaibuchi K: Neuronal polarity: from extracellular signals to intracellular mechanisms. Nat Rev Neurosci 2007; 8: 194-205.
97. Barnes AP, Solecki D, Polleux F: New sights into the molecular mechanisms specifying neuronal polarity in vivo. Curr Opin Neu-robiol 2008; 18: 44-52.
98. Cajal Y, Berg OG, Jain MK: Direct vesicle-vesicle exchange of phospholipids mediated by polymyxin B. Biochem Biophys Res Commun 1995; 210:746-752.
99. Xiong YA, Huang CH, Iglesias PA, Devreotes PN: Cells navigate with a local-excitation, global-inhibition-biased excitable network. Proc Natl Acad Sci USA 2010; 107:17079-17086.
100. Shelly M, Lim BK, Cancedda L, Heilshorn SC, Gao HF, Poo MM: Local and long-range reciprocal regulation of cAMP and cGMP in axon/dendrite formation. Science 2010; 327:547-552.
101. Cheng PL, Song AH, Wong YH, Wang S, Zhang X, Poo MM: Self-amplifying auto-crine actions of BDNF in axon development. Proc Natl Acad Sci USA 2011; 108: 18430-18435.
102. Hutchins BI: Competitive outgrowth of neural processes arising from long-distance cAMP signaling. Sci Signal 2010; 3:jc1.
103. Shelly M, Cancedda L, Lim BK, Popescu AT, Cheng PL, Gao HF, Poo MM: Semapho-rin3a regulates neuronal polarization by suppressing axon formation and promoting dendrite grow th. Neuron 2011; 71: 433-446.
104. Dickson BJ: Rho GTPases in growth cone guidance. Curr Opin Neurobiol 2001; 11: 103-110.
105. Luo L: Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000; 1:173-180.
106. Hsieh C, Brown S, Derleth C, Mackie K: In-ternalization and recycling of the CB1 can-nabinoid receptor. J Neurochem 1999; 73: 493-501.
107. Nyiri G, Cserep C, Szabadits E, Mackie K, Freund TF: CB-1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 2005; 136: 811-822.
108. Huizink AC, Mulder EJH: Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 2006; 30: 24-41.
109. Bullmore E, Sporns O: Complex brain networks. Graph theoretical analysis of structural and functional systems. Nat Rev Neu-rosci 2009; 10: 186.
110. Aguado T, Romero E, Monory K, Palazue-los J, Sendtner M, Marsicano G, Lutz B, Guzman M, Galve-Roperh I: The CB1 can-nabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem 2007; 282: 23892-23898.
111. Krebs-Kraft DL, Hill MN, Hillard CJ, McCarthy MM: Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior. Proc Natl Acad Sci USA 2010; 107: 20535-20540.
112. Lom B, Hopker V, McFarlane S, Bixby JL, Holt CE: Fibroblast growth factor receptor signaling in Xenopus retinal axon extension. J Neurobiol 1998; 37: 633-641.